Figure 2
From: From identification of the BTK kinase to effective management of leukemia
Chemical structure of ibrutinib (MW 440.5) and of acalabrutinib (MW 465.5), which both compete with the binding of adenosine triphosphate (ATP) to BTK. ATP (MW 507.2) is included for comparison.
